Bone loss and increased bone adiposity in spontaneous and pharmacologically induced diabetic mice - PubMed (original) (raw)
Comparative Study
. 2007 Jan;148(1):198-205.
doi: 10.1210/en.2006-1006. Epub 2006 Oct 19.
Affiliations
- PMID: 17053023
- DOI: 10.1210/en.2006-1006
Comparative Study
Bone loss and increased bone adiposity in spontaneous and pharmacologically induced diabetic mice
Sergiu Botolin et al. Endocrinology. 2007 Jan.
Abstract
Insulin-dependent diabetes mellitus (IDDM) is associated with increased risk of osteopenia/osteoporosis in humans. The mechanisms accounting for diabetic bone loss remain unclear. Pharmacologic inducers of IDDM, such as streptozotocin, mimic key aspects of diabetes in rodents, allow analysis at the onset of diabetes, and induce diabetes in genetically modified mice. However, side effects of streptozotocin, unrelated to diabetes, can complicate data interpretation. The nonobese diabetic (NOD) mouse model develops diabetes spontaneously without external influences, negating side effects of inducing agents. Unfortunately, in this model the onset of diabetes is unpredictable, occurs in a minority of male mice, and can only be studied in a single mouse strain. To validate the relevance of the more flexible streptozotocin-induced diabetes model for studying diabetes-associated bone loss, we compared its phenotype to the spontaneously diabetic NOD model. Both models exhibited hyperglycemia and loss of body, fat pad, and muscle weight. Furthermore, these genetically different and distinct models of diabetes induction demonstrated similar bone phenotypes marked by significant trabecular bone loss and increased bone marrow adiposity. Correspondingly, both diabetic models exhibited decreased osteocalcin mRNA and increased adipocyte fatty acid-binding protein 2 mRNA levels in isolated tibias and calvaria. Taken together, multiple streptozotocin injection-induced diabetes is a valid model for understanding the acute and chronic pathophysiologic responses to diabetes and their mechanisms in bone.
Similar articles
- Type I diabetic bone phenotype is location but not gender dependent.
Martin LM, McCabe LR. Martin LM, et al. Histochem Cell Biol. 2007 Aug;128(2):125-33. doi: 10.1007/s00418-007-0308-4. Epub 2007 Jul 3. Histochem Cell Biol. 2007. PMID: 17609971 - Histomorphometric analysis of diabetic osteopenia in streptozotocin-induced diabetic mice: a possible role of oxidative stress.
Hamada Y, Kitazawa S, Kitazawa R, Fujii H, Kasuga M, Fukagawa M. Hamada Y, et al. Bone. 2007 May;40(5):1408-14. doi: 10.1016/j.bone.2006.12.057. Epub 2006 Dec 24. Bone. 2007. PMID: 17251074 - Both spontaneous Ins2(+/-) and streptozotocin-induced type I diabetes cause bone loss in young mice.
Coe LM, Zhang J, McCabe LR. Coe LM, et al. J Cell Physiol. 2013 Apr;228(4):689-95. doi: 10.1002/jcp.24177. J Cell Physiol. 2013. PMID: 22886636 - Understanding the pathology and mechanisms of type I diabetic bone loss.
McCabe LR. McCabe LR. J Cell Biochem. 2007 Dec 15;102(6):1343-57. doi: 10.1002/jcb.21573. J Cell Biochem. 2007. PMID: 17975793 Review. - Animal models of diabetic uropathy.
Daneshgari F, Leiter EH, Liu G, Reeder J. Daneshgari F, et al. J Urol. 2009 Dec;182(6 Suppl):S8-13. doi: 10.1016/j.juro.2009.07.084. J Urol. 2009. PMID: 19846143 Free PMC article. Review.
Cited by
- Systemic Deletion of ARRDC4 Improves Cardiac Reserve and Exercise Capacity in Diabetes.
Nakayama Y, Kobayashi S, Masihuddin A, Abdali SA, Seneviratne AMPB, Ishii S, Iida J, Liang Q, Yoshioka J. Nakayama Y, et al. Circ Res. 2024 Jul 19;135(3):416-433. doi: 10.1161/CIRCRESAHA.123.323158. Epub 2024 Jul 1. Circ Res. 2024. PMID: 38946541 - Associations of marrow fat fraction with MR imaging based trabecular bone microarchitecture in first-time diagnosed type 1 diabetes mellitus.
Li W, Wang W, Zhang M, Chen Q, Li S. Li W, et al. Front Endocrinol (Lausanne). 2024 May 7;15:1287591. doi: 10.3389/fendo.2024.1287591. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38774224 Free PMC article. - Bone Marrow Adipose Tissue.
Marinelli Busilacchi E, Morsia E, Poloni A. Marinelli Busilacchi E, et al. Cells. 2024 Apr 23;13(9):724. doi: 10.3390/cells13090724. Cells. 2024. PMID: 38727260 Free PMC article. Review. - O-linked β-N-acetylglucosaminylation may be a key regulatory factor in promoting osteogenic differentiation of bone marrow mesenchymal stromal cells.
Zhou XC, Ni GX. Zhou XC, et al. World J Stem Cells. 2024 Mar 26;16(3):228-231. doi: 10.4252/wjsc.v16.i3.228. World J Stem Cells. 2024. PMID: 38577231 Free PMC article. - Sarm1 knockout prevents type 1 diabetic bone disease in females independent of neuropathy.
Brazill JM, Shen IR, Craft CS, Magee KL, Park JS, Lorenz M, Strickland A, Wee NK, Zhang X, Beeve AT, Meyer GA, Milbrandt J, DiAntonio A, Scheller EL. Brazill JM, et al. JCI Insight. 2024 Jan 4;9(4):e175159. doi: 10.1172/jci.insight.175159. JCI Insight. 2024. PMID: 38175722 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials